FDA Approved: ARRANON — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for ARRANON (nelarabine) from Sandoz Inc. This action concerns the supplemental NDA submitted by Sandoz to update the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• ARRANON (nelarabine)

Snippet

SUPPL AP for ARRANON (NELARABINE)